Moleculin Biotech, Inc.
MBRX
$2.40
-$0.01-0.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -39.97M | -33.03M | -55.16M | -30.30M | -26.98M |
| Total Depreciation and Amortization | 67.00K | 90.00K | 112.00K | 122.00K | 125.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.64M | 9.65M | 32.88M | 6.89M | 3.29M |
| Change in Net Operating Assets | 980.00K | 555.00K | -278.00K | 1.95M | 1.86M |
| Cash from Operations | -24.28M | -22.74M | -22.45M | -21.34M | -21.71M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -13.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | 0.00 | -13.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 26.91M | 27.29M | 19.80M | 18.08M | 12.66M |
| Repurchase of Common Stock | -8.00K | -8.00K | 0.00 | -1.00K | -26.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 26.90M | 27.28M | 19.80M | 18.08M | 12.63M |
| Foreign Exchange rate Adjustments | -14.00K | 51.00K | -48.00K | -28.00K | -20.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.60M | 4.60M | -2.70M | -3.29M | -9.11M |